Related Experiment Videos
New directions in supportive care
Abstract:
Supportive care has traditionally emphasized symptom management and subjective evaluation of quality of life. However, recent advances in molecular biology and molecular genetics are as exciting for supportive care as they are for cytotoxic therapy. Relevant receptor mutations may alter sensitivity to antiemetics or to analgesics while variations in metabolic pathways may affect either efficacy of supportive care agents or toxicity of the chemotherapeutic agents themselves. Altered ligands for various receptors can produce differential effects conducive to better symptom management. Even symptoms such as fatigue and overall outlook may be defined in terms of appropriate enzymatic pathways. Evaluation and application of these advances in basic science are leading directly to new directions in supportive care.
Insights
Molecular advances in supportive care enhance symptom management and quality of life. Understanding genetic variations improves treatment efficacy and reduces chemotherapy toxicity.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Traditional supportive care focuses on symptom management and quality of life.
- Recent molecular biology and genetics advances offer new avenues for supportive care.
Purpose of the Study:
- To explore how molecular and genetic advancements can refine supportive care strategies.
- To investigate the impact of genetic variations on supportive care agent efficacy and toxicity.
Main Methods:
- Analysis of receptor mutations and their effect on antiemetic and analgesic sensitivity.
- Investigation of metabolic pathway variations influencing supportive care and chemotherapy outcomes.
- Exploration of altered receptor ligands for improved symptom management.
- Defining symptoms like fatigue and outlook through enzymatic pathways.
Main Results:
- Receptor mutations can alter patient sensitivity to supportive care medications.
- Metabolic pathway variations impact both supportive care agent effectiveness and chemotherapy toxicity.
- Altered receptor ligands offer potential for differential effects in symptom management.
- Enzymatic pathways provide a molecular basis for understanding symptoms like fatigue.
Conclusions:
- Molecular and genetic insights are revolutionizing supportive care.
- Personalized approaches based on individual genetic profiles can optimize supportive care.
- These advancements promise more effective symptom management and improved patient outcomes in cancer therapy.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:30Current Trends in Nursing II
01:21Interdisciplinary Care: The Health Care Team-I
Physicians
The physician's primary responsibility is to diagnose illness and direct the medical or surgical treatment of the condition. The authority to admit patients to a healthcare agency or institution and practice care within that setting is granted to physicians by the healthcare agency or institution itself.
01:18Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
01:19Standards of Care II